Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT: Chelation Therapy in Post-MI Patients
NCT00044213Phase 3Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Sep 2003
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of edetate disodium in coronary artery disease (CAD), sponsored by Mount Sinai Medical Center. Started Sep 2003; status: completed.
02
Drugs
edetate disodium
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00044213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044213.